Discover why Viking Therapeutics, Inc.'s VK2735 could lead GLP-1 obesity drugs. Click for my updated look at VKTX stock ...

The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organization (CDSCO), has opined ...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: ...

As the LA Angels stand trial over the pitcher’s death in the quiet shadow of the World Series fanfare across town, a sport ...

The approval of Yesintek and Yesintek I.V., biosimilars to Stelara, strengthens Biocon Biologics' presence in North America and expands its immunology portfolio ...

Roche's Q3 sales climbed 6% to CHF 14.9B, powered by surging demand for Phesgo, Xolair, Hemlibra, Vabysmo, and Ocrevus.

The new approvals bring the number of denosumab biosimilars in the US to eight, but price reductions are not yet substantial.

Biocon Ltd on Thursday said its arm Biocon Biologics Ltd has received an approval from Health Canada for chronic autoimmune ...

AstraZeneca’s Saphnelo (anifrolumab) has received a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) for approval in the European Union as a self-administered, ...

Bengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that Health Canada has granted a Notice of ...

Clinical Director of the National Institute of Drug Abuse Dr. Lorenzo Leggio, said GLP-1 drugs' effect on the brain can help ...

Biocon Biologics gets Health Canada nod for Yesintek and Yesintek IV, a biosimilar to Stelara: Our Bureau, Bengaluru Thursday, October 23, 2025, 14:30 Hrs [IST] Biocon Biologics L ...